Danaher completes merger of Cytiva and Pall Corp.’s life sciences business


The combined entity accounts for roughly $7.5 billion in annual bioprocess revenue.

Previous Company with line of EV chargers buys Triad industrial facility for $13.5 million
Next Charlotte-based Kian Capital closes $400M fund for middle-market companies